MORGAN STANLEY PLC/CALL/UNITEDHEALTH GROUP/590/0.1/20.09.24 Stock

Warrant

DE000MB03E71

Market Closed - Börse Stuttgart 14:49:39 2024-07-04 EDT
0.23 EUR +4.55% Intraday chart for MORGAN STANLEY PLC/CALL/UNITEDHEALTH GROUP/590/0.1/20.09.24
1 month-28.12%
3 months-8.00%
Date Price Change
24-07-04 0.23 +4.55%
24-07-03 0.22 -8.33%
24-07-02 0.24 0.00%
24-07-01 0.24 +4.35%
24-06-28 0.23 +23.66%

Delayed Quote Börse Stuttgart

Last update July 04, 2024 at 02:49 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying UNITEDHEALTH GROUP INC.
Issuer Morgan Stanley
WKN MB03E7
ISINDE000MB03E71
Date issued 2022-11-03
Strike 590 $
Maturity 2024-09-20 (78 Days)
Parity 10 : 1
Emission price 10.55
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 9.02
Lowest since issue 0.159
Delta0.1x
Omega 17.03
Premium21.01x
Gearing174.27x
Moneyness 0.8303
Difference Strike 100.1 $
Difference Strike %+16.97%
Spread 0.06
Spread %20.69%
Theoretical value 0.2600
Implied Volatility 28.47 %
Total Loss Probability 92.29 %
Intrinsic value 0.000000
Present value 0.2600
Break even 592.81 €
Theta-0.05x
Vega0.04x
Rho0.01x

Company Profile

UnitedHealth Group Inc. is one of the leading American suppliers of healthcare products and services. Income breaks down by activity as follows: - health insurance (57.4%; UnitedHealthcare); - prescription insurance plan management services (39.3%; Optum Health and Optum Rx): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - provision of computer services (3.3%; Optum Insight): consulting, development, and integration of solutions for transaction management, healthcare plan management, data processing, etc.
Sector
-
More about the company

Ratings for UnitedHealth Group Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: UnitedHealth Group Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
489.9 USD
Average target price
575.8 USD
Spread / Average Target
+17.53%
Consensus